HDR Gateway logo
HDR Gateway logo

Bookmarks

CCU001: Investigating the effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 outcomes

Safe People

Organisation name

University of Bristol

Organisation sector

Academic Institute

Applicant name(s)

Jonathan Sterne

Sub-licence arrangements (if any)?

No

Safe Projects

Project ID

CCU001

Lay summary

ACE inhibitors and angiotensin receptor blockers are drugs that are commonly used to lower high blood pressure. These drugs may affect the ability of the coronavirus to enter cells of the body and cause COVID-19. We plan to investigate whether use of these drugs affects people’s chance of becoming infected or unwell with COVID-19. We will conduct carefully planned analyses of data from millions of people’s healthcare records. These records provide information about people’s health and prescribed medications, as well as on which people became infected or unwell with COVID-19. People who take drugs to lower their blood pressure are more likely to have other risk factors for becoming infected or unwell with COVID-19. Our analysis methods will account for these risk factors, to work out whether any change in risk is due to the blood pressure lowering drugs themselves. Our results will help to inform the way that blood pressure lowering drugs are used in the future, particularly while the pandemic continues.

Public benefit statement

Our results will help to inform the way that blood pressure lowering drugs are used in the future, particularly while the pandemic continues.

Latest approval date

30/10/2020

Safe Data

Dataset(s) name
Data sensitivity level

De-Personalised

Safe Setting

Access type

TRE